Injecting Risk Behavior among Traveling Young Injection Drug Users: Travel Partner and City Characteristics

• Published in: Journal of urban health 2013-06, Vol.90 (3), p.500-515
• Main Authors: Montgomery, Martha E., Fatch, Robin S., Evans, Jennifer L., Yu, Michelle, Davidson, Peter J., Page, Kimberly, Hahn, Judith A.
• Format: Article
• Language: English
• Subjects: Adolescent; Adult; Alcohol Drinking - epidemiology; Alcoholic beverages; Cities; Drug use; Epidemiology; Female; Follow-Up Studies; Health Informatics; Humans; Injection; Injections; Male; Medicine; Medicine & Public Health; Multivariate Analysis; Needle Sharing - statistics & numerical data; Needle-Exchange Programs; Prospective Studies; Public Health; Risk taking; Self Report; Sexual Partners; Substance Abuse, Intravenous - epidemiology; Travel; United States - epidemiology; Young Adult; Young adults
• ISSN: 1099-3460; 1468-2869
• DOI: 10.1007/s11524-012-9718-2

Young injection drug users (IDUs), a highly mobile population, engage in high levels of injecting risk behavior, yet little is understood about how such risk behavior may vary by the characteristics of the cities to which they travel, including the existence of a syringe exchange program (SEP), as well as travel partner characteristics. In 2004–2005, we conducted a 6-month prospective study to investigate the risk behavior of 89 young IDUs as they traveled, with detailed information gathered about 350 city visits. In multivariable analyses, travel to larger urban cities with a population of 500,000–1,000,000 was significantly associated with injecting drugs (adjusted odds ratio (AOR) = 3.71; 95 % confidence interval (CI), 1.56–8.82), ancillary equipment sharing (AES; AOR = 7.05; 95 % CI, 2.25–22.06) and receptive needle sharing (RNS; AOR = 5.73; 95 % CI, 1.11–27.95), as compared with visits to smaller cities with populations below 50,000. Region of the country, and the existence of a SEP within the city visited, were not independently associated with injecting drugs, AES, or RNS during city visits. Traveling with more than one injecting partner was associated with injecting drugs during city visits (AOR = 2.77; 95 % CI, 1.46–5.27), when compared with traveling alone. Additionally, both non-daily and daily/almost daily alcohol use during city visits were associated with AES (AOR = 3.37; 95 % CI, 1.42–7.68; AOR = 3.03; 95 % CI, 1.32–6.97, respectively) as compared with no alcohol consumption. Traveling young IDUs are more likely to inject when traveling with other IDUs and to engage in higher risk injection behavior when they are in large cities. Risk behavior occurring in city visits, including equipment sharing and alcohol consumption, suggests further need for focused interventions to reduce risk for viral infection among this population.